The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Highly prognostic signature for stage II colon cancer from the TOSCA trial: The PROSIT study.
 
Alberto Puccini
No Relationships to Disclose
 
Lorenzo Ferrando
No Relationships to Disclose
 
Luca Mazzarella
No Relationships to Disclose
 
Gianmaria Frige
No Relationships to Disclose
 
Anna Maria Pessino
No Relationships to Disclose
 
Alessandro Pastorino
Honoraria - Amgen; MSD; Pierre Fabre; SERVIER
Consulting or Advisory Role - Merck; Pierre Fabre
Travel, Accommodations, Expenses - Amgen; AstraZeneca; SERVIER
 
Valentino Martelli
No Relationships to Disclose
 
Anna Garuti
No Relationships to Disclose
 
Veronica Di Antonio
No Relationships to Disclose
 
Alberto Ballestrero
No Relationships to Disclose
 
Valter Torri
No Relationships to Disclose
 
Roberto Labianca
No Relationships to Disclose
 
Matteo Fassan
Consulting or Advisory Role - Amgen; Amgen; Astellas Pharma; AstraZeneca; GlaxoSmithKline; Incyte; Janssen; Lilly; MSD Oncology; Novartis; Pierre Fabre; Roche
Research Funding - Astellas Pharma; Diaceutics; Macrophage Pharma; QED Therapeutics
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Gabriele Zoppoli
Stock and Other Ownership Interests - Immunomica S.r.l.
Speakers' Bureau - Novartis
Research Funding - Thermo Fisher Scientific (Inst)
Patents, Royalties, Other Intellectual Property - European patent no. 102019000018989 concerning a "multi-domain method for prediction of one-year mortality in senior patients diagnosed with cancer"
Travel, Accommodations, Expenses - Novartis; Roche
 
Alberto F. Sobrero
Consulting or Advisory Role - Amgen; Bayer; BMS; GlaxoSmithKline; Hutchmed; MSD Oncology; SERVIER
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Takeda
Travel, Accommodations, Expenses - Bayer